Assessing potential MYC genomic amplification, and using computational approaches to assess the functionality of the molecular clock in tumor cells (discussed in more detail below) will be required to fully appreciate the role of MYC in modulating circadian rhythms in human cancer cells. The gene discussed is CLOCK; the disease is neoplasm.